Related Experiment Videos
[The competence network "acute and chronic leukemias"].
1Netzwerkzentrale des Kompetenznetzes "Akute und chronische Leukämien", III. Medizinische Universitätsklinik, Klinikum Mannheim der Universität Heidelberg. r.hehlmann@urz.uni-heidelberg.de
Deutsche Medizinische Wochenschrift (1946)
|December 4, 2004
Summary
A German network integrates leading leukemia research groups to overcome fragmentation and advance patient care. This collaboration fosters clinical trials, translational research, and standardized diagnostics for better leukemia treatment outcomes.
Area of Science:
- Hematology
- Oncology
- Translational Research
Context:
- Leukemias pose significant societal challenges and costs due to their prevalence across all age groups.
- Leukemia research holds exemplary relevance for basic science and clinical patient care.
- Despite high standards in German leukemia research, progress is hindered by fragmented trial groups and research activities.
Purpose:
- To establish a network integrating leading German leukemia trial groups (CML, AML, ALL, MDS, CMPD) and interdisciplinary partners.
- To foster advancements in leukemia research and healthcare through enhanced clinical trials and translational research.
- To promote the development of standardized diagnostics, therapies, and evidence-based guidelines.
Summary:
- A network was created to integrate leading German leukemia trial groups and interdisciplinary partners, including basic research and industry.
- Key achievements include establishing central information structures, an AML intergroup, an MDS study group, and platforms for diagnostics, genomics, proteomics, and medical informatics.
- Scientific progress is disseminated through various channels, including internet platforms, newsletters, meetings, and symposia.
Impact:
- The network is restructuring leukemia therapy and research in Germany.
- It supports the dissemination of scientific excellence in the field of leukemias.
- This integrated approach aims to improve outcomes for leukemia patients through collaborative research and standardized care.